UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - PORTOLA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,420,383,000
+133.5%
78,954
-7.5%
0.00%
Q1 2020$608,419,000
-67.2%
85,332
+9.8%
0.00%
-100.0%
Q4 2019$1,855,977,000
-3.3%
77,721
+8.6%
0.00%0.0%
Q3 2019$1,919,669,000
+35.5%
71,576
+37.0%
0.00%0.0%
Q2 2019$1,417,080,000
-87.2%
52,233
-83.6%
0.00%
-87.5%
Q1 2019$11,053,719,000
+60.4%
318,551
-9.8%
0.01%
+33.3%
Q4 2018$6,892,122,000
-20.9%
353,080
+7.9%
0.01%0.0%
Q3 2018$8,712,802,000
-31.9%
327,180
-3.4%
0.01%
-40.0%
Q2 2018$12,796,098,000
+8.0%
338,790
-6.6%
0.01%
+11.1%
Q1 2018$11,844,313,000
-35.2%
362,655
-3.4%
0.01%
-40.0%
Q4 2017$18,281,190,000
+19.5%
375,538
+32.6%
0.02%
+7.1%
Q3 2017$15,297,460,000
-1.3%
283,129
+2.6%
0.01%
-6.7%
Q2 2017$15,506,684,000
-1.0%
276,067
-30.9%
0.02%
-6.2%
Q1 2017$15,663,616,000
+230484.7%
399,684
+32.0%
0.02%
+100.0%
Q4 2016$6,793,000
-5.8%
302,722
-4.7%
0.01%0.0%
Q3 2016$7,213,000
-3.8%
317,616
-0.0%
0.01%0.0%
Q2 2016$7,499,000
+11.6%
317,772
-3.5%
0.01%0.0%
Q1 2016$6,718,000
-34.6%
329,314
+65.1%
0.01%
-33.3%
Q4 2015$10,266,000
+16.9%
199,521
-3.2%
0.01%
+20.0%
Q3 2015$8,782,000
+124.7%
206,061
+140.2%
0.01%
+150.0%
Q2 2015$3,908,000
+508.7%
85,797
+407.7%
0.00%
+300.0%
Q1 2015$642,000
+138.7%
16,900
+77.9%
0.00%
Q4 2014$269,000
+30.0%
9,500
+15.9%
0.00%
Q3 2014$207,0000.0%8,200
+15.5%
0.00%
Q2 2014$207,0007,1000.00%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,220,672$52,025,0008.00%
Fernwood Investment Management, LLC 190,011$8,098,0007.10%
Cormorant Asset Management, LP 500,000$21,310,0003.40%
HARVEY CAPITAL MANAGEMENT INC 157,930$6,730,0002.69%
Atika Capital Management LLC 128,000$5,456,0002.68%
Redmile Group, LLC 769,641$32,802,0002.48%
Temasek Holdings (Private) Ltd 5,833,568$248,627,0002.36%
SECTORAL ASSET MANAGEMENT INC 1,088,118$46,376,0002.12%
Eventide Asset Management 479,900$20,453,0001.19%
BBT Capital Management, LLC 200,000$8,524,0000.79%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders